SRL
APRE icon

Scientech Research LLC’s Aprea Therapeutics APRE Stock Holding History

Scientech Research LLC’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46K Buy
+60,281
New +$47.4K 0.04% 416

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Scientech Research LLC's APRE Position: Q1 2026 in Review

Scientech Research LLC opened a new position in Aprea Therapeutics (APRE) in Q1 2026: 60,281 shares worth $46K. The stake represents 0.04% of the portfolio and ranks #416 among its holdings.

22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Scientech Research LLC held 60,281 shares of Aprea Therapeutics worth $46K as of Q1 2026.
  • Aprea Therapeutics was a new Scientech Research LLC position in Q1 2026.
  • Aprea Therapeutics made up 0.04% of Scientech Research LLC's portfolio in Q1 2026, its #416 holding.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.